Clinical Trial

The PvCO2-PaCO2/CaO2-CvO2 Ratio in Septic Shock

Study acronym: SepsisO2CO2R
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 31, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The ratio of the venous-arterial carbon dioxide partial pressure difference to the arteriovenous oxygen content difference (Pv-aCO₂/Ca-vO₂) may be a marker of anaerobic metabolism in patients with acute circulatory failure. This study aims to assess the prognostic value of the PvCO2-PaCO2/CaO2-CvO2 in the early phase of septic shock.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-29.
Trial Details
NCT Number NCT07096284
Lead Sponsor Avicenna Military Hospital
Conditions Septic Shock
Enrollment 30 participants
Start Date 2025-01-05
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-31